Targeting the IL-12/IL-23 axis: An alternative approach to removing tumor induced immune suppression

gan Smyth, Mark J, Teng, Michele W L
Cyhoeddwyd 2014

Interleukin (IL)-12 and IL-23 and Their Conflicting Roles in Cancer

gan Yan, Juming, Smyth, Mark J., Teng, Michele W.L.
Cyhoeddwyd yn Cold Spring Harb Perspect Biol (2018)

Acquired resistance to anti-PD1 therapy: checkmate to checkpoint blockade?

gan O’Donnell, Jake S., Smyth, Mark J., Teng, Michele W. L.
Cyhoeddwyd yn Genome Med (2016)

PD1 functions by inhibiting CD28-mediated co-stimulation

gan O'Donnell, Jake S, Smyth, Mark J, Teng, Michele W L
Cyhoeddwyd yn Clin Transl Immunology (2017)

Classifying cancers based on T cell infiltration and PD-L1

gan Teng, Michele W. L., Ngiow, Shin Foong, Ribas, Antoni, Smyth, Mark J.
Cyhoeddwyd yn Cancer Res (2015)

From mice to humans: developments in cancer immunoediting

gan Teng, Michele W.L., Galon, Jerome, Fridman, Wolf-Herman, Smyth, Mark J.
Cyhoeddwyd yn J Clin Invest (2015)

CD1d Activation and Blockade: A New Antitumor Strategy

gan Teng, Michele W. L., Yue, Simon, Sharkey, Janelle, Exley, Mark A., Smyth, Mark J.
Cyhoeddwyd 2009

The interaction between murine melanoma and the immune system reveals that prolonged responses predispose for autoimmunity

gan Ngiow, Shin Foong, von Scheidt, Bianca, Möller, Andreas, Smyth, Mark J., Teng, Michele W. L.
Cyhoeddwyd 2013

CD1d-Based Combination Therapy Eradicates Established Tumors in Mice

gan Teng, Michele W. L., Sharkey, Janelle, McLaughlin, Nicole M., Exley, Mark A., Smyth, Mark J.
Cyhoeddwyd 2009

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome

gan Liu, Jing, O’Donnell, Jake S., Yan, Juming, Madore, Jason, Allen, Stacey, Smyth, Mark J., Teng, Michele W. L.
Cyhoeddwyd yn Oncoimmunology (2019)

RANKL blockade improves efficacy of PD1-PD-L1 blockade or dual PD1-PD-L1 and CTLA4 blockade in mouse models of cancer

gan Ahern, Elizabeth, Harjunpää, Heidi, O'Donnell, Jake S., Allen, Stacey, Dougall, William C., Teng, Michele W. L., Smyth, Mark J.
Cyhoeddwyd yn Oncoimmunology (2018)

The role of NK cells and CD39 in the immunological control of tumor metastases

gan Zhang, Haiyan, Vijayan, Dipti, Li, Xian-Yang, Robson, Simon C., Geetha, Nishamol, Teng, Michele W. L., Smyth, Mark J.
Cyhoeddwyd yn Oncoimmunology (2019)

TIM3(+)FOXP3(+) regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer

gan Sakuishi, Kaori, Ngiow, Shin Foong, Sullivan, Jenna M., Teng, Michele W. L., Kuchroo, Vijay K., Smyth, Mark J., Anderson, Ana C.
Cyhoeddwyd 2013

Opposing roles for IL-23 and IL-12 in maintaining occult cancer in an equilibrium state

gan Teng, Michele W. L., Vesely, Matthew D., Duret, Helene, McLaughlin, Nicole, Towne, Jennifer E., Schreiber, Robert D., Smyth, Mark J.
Cyhoeddwyd yn Cancer Res (2012)

Batf3(+) DCs and type I IFN are critical for the efficacy of neoadjuvant cancer immunotherapy

gan Liu, Jing, Rozeman, Elisa A., O’Donnell, Jake S., Allen, Stacey, Fanchi, Lorenzo, Smyth, Mark J., Blank, Christian U., Teng, Michele W.L.
Cyhoeddwyd yn Oncoimmunology (2018)

Selective activation of anti-CD73 mechanisms in control of primary tumors and metastases

gan Vijayan, Dipti, Barkauskas, Deborah S., Stannard, Kimberley, Sult, Erin, Buonpane, Rebecca, Takeda, Kazuyoshi, Teng, Michele W. L., Sachsenmeier, Kris, Hay, Carl, Smyth, Mark J.
Cyhoeddwyd yn Oncoimmunology (2017)

TIGIT predominantly regulates the immune response via regulatory T cells

gan Kurtulus, Sema, Sakuishi, Kaori, Ngiow, Shin-Foong, Joller, Nicole, Tan, Dewar J., Teng, Michele W.L., Smyth, Mark J., Kuchroo, Vijay K., Anderson, Ana C.
Cyhoeddwyd yn J Clin Invest (2015)

Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multi...

gan Ahern, Elizabeth, Cubitt, Annette, Ballard, Emma, Teng, Michele W. L., Dougall, William C., Smyth, Mark J., Godbolt, David, Naidoo, Rishendran, Goldrick, Amanda, Hughes, Brett G. M.
Cyhoeddwyd yn Trials (2019)

CD96 targeted antibodies need not block CD96-CD155 interactions to promote NK cell anti-metastatic activity

gan Roman Aguilera, Amelia, Lutzky, Viviana P., Mittal, Deepak, Li, Xian-Yang, Stannard, Kimberley, Takeda, Kazuyoshi, Bernhardt, Günter, Teng, Michele W. L., Dougall, William C., Smyth, Mark J.
Cyhoeddwyd yn Oncoimmunology (2018)

IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis

gan Teng, Michele W. L., Andrews, Daniel M., McLaughlin, Nicole, von Scheidt, Bianca, Ngiow, Shin Foong, Möller, Andreas, Hill, Geoffrey R., Iwakura, Yoichiro, Oft, Martin, Smyth, Mark J.
Cyhoeddwyd 2010